Anti-neutrophil cytoplasmic antibody positive vasculitis
Not yet recruitingTesting avacopan added to standard treatment in patients with ANCA-associated vasculitis with severe kidney damage
Testing avacopan added to standard treatment in patients with ANCA-associated vasculitis with severe kidney damage
- Disease:Anti-neutrophil cytoplasmic antibody positive vasculitis
- Substances:AvacopanCyclophosphamide+5
France- Participants:18–64 years · 65+ years
- Substances:Avacopan
- Sponsor:Centre Hospitalier Universitaire De Toulouse





